These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26384561)

  • 61. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
    Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
    Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations.
    Shen B; Chapman JH; Custance MF; Tricola GM; Jones CE; Furano AV
    Elife; 2020 Jan; 9():. PubMed ID: 31904337
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
    Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
    J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
    [TBL] [Abstract][Full Text] [Related]  

  • 65. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
    Cescon DW; Haibe-Kains B; Mak TW
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
    [TBL] [Abstract][Full Text] [Related]  

  • 66. APOBEC3B and AID have similar nuclear import mechanisms.
    Lackey L; Demorest ZL; Land AM; Hultquist JF; Brown WL; Harris RS
    J Mol Biol; 2012 Jun; 419(5):301-14. PubMed ID: 22446380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.
    Bogerd HP; Kornepati AV; Marshall JB; Kennedy EM; Cullen BR
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7249-56. PubMed ID: 26668372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure-Guided Design of a Potent and Specific Inhibitor against the Genomic Mutator APOBEC3A.
    Serrano JC; von Trentini D; Berríos KN; Barka A; Dmochowski IJ; Kohli RM
    ACS Chem Biol; 2022 Dec; 17(12):3379-3388. PubMed ID: 36475588
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lentivirus restriction by diverse primate APOBEC3A proteins.
    Schmitt K; Guo K; Katuwal M; Wilson D; Prochnow C; Bransteitter R; Chen XS; Santiago ML; Stephens EB
    Virology; 2013 Jul; 442(1):82-96. PubMed ID: 23648232
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
    Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
    PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
    [TBL] [Abstract][Full Text] [Related]  

  • 71. APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts.
    Niavarani A; Currie E; Reyal Y; Anjos-Afonso F; Horswell S; Griessinger E; Luis Sardina J; Bonnet D
    PLoS One; 2015; 10(3):e0120089. PubMed ID: 25807502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structural Characterization of a Minimal Antibody against Human APOBEC3B.
    Tang H; Demir Ö; Kurniawan F; Brown WL; Shi K; Moeller NH; Carpenter MA; Belica C; Orellana K; Du G; LeBeau AM; Amaro RE; Harris RS; Aihara H
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.
    Tsuboi M; Yamane A; Horiguchi J; Yokobori T; Kawabata-Iwakawa R; Yoshiyama S; Rokudai S; Odawara H; Tokiniwa H; Oyama T; Takeyoshi I; Nishiyama M
    Breast Cancer; 2016 Sep; 23(5):780-8. PubMed ID: 26476745
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.
    Siriwardena SU; Guruge TA; Bhagwat AS
    J Mol Biol; 2015 Sep; 427(19):3042-55. PubMed ID: 26281709
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
    Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
    Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
    Kouno T; Silvas TV; Hilbert BJ; Shandilya SMD; Bohn MF; Kelch BA; Royer WE; Somasundaran M; Kurt Yilmaz N; Matsuo H; Schiffer CA
    Nat Commun; 2017 Apr; 8():15024. PubMed ID: 28452355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.
    Argyris PP; Naumann J; Jarvis MC; Wilkinson PE; Ho DP; Islam MN; Bhattacharyya I; Gopalakrishnan R; Li F; Koutlas IG; Giubellino A; Harris RS
    Histopathology; 2023 Mar; 82(4):608-621. PubMed ID: 36416305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.